20-13048957-C-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_018327.4(SPTLC3):ā€‹c.130C>Gā€‹(p.Pro44Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000399 in 1,553,624 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00017 ( 0 hom., cov: 32)
Exomes š‘“: 0.000026 ( 0 hom. )

Consequence

SPTLC3
NM_018327.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.346
Variant links:
Genes affected
SPTLC3 (HGNC:16253): (serine palmitoyltransferase long chain base subunit 3) This gene encodes a subunit of the serine palmitoyltransferase complex which catalyzes the rate-limiting step in sphingolipid biosynthesis. This subunit metabolizes lauroyl- and myristoyl-CoA and generates C14 and C16-sphingoid bases. [provided by RefSeq, Mar 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.023374766).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SPTLC3NM_018327.4 linkuse as main transcriptc.130C>G p.Pro44Ala missense_variant 2/12 ENST00000399002.7 NP_060797.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SPTLC3ENST00000399002.7 linkuse as main transcriptc.130C>G p.Pro44Ala missense_variant 2/121 NM_018327.4 ENSP00000381968 P1Q9NUV7-1
SPTLC3ENST00000476791.1 linkuse as main transcriptn.419C>G non_coding_transcript_exon_variant 2/21
SPTLC3ENST00000450297.1 linkuse as main transcriptc.49C>G p.Pro17Ala missense_variant 2/53 ENSP00000409125
SPTLC3ENST00000434210.5 linkuse as main transcriptc.130C>G p.Pro44Ala missense_variant 3/43 ENSP00000389749

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
26
AN:
152076
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000266
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000957
GnomAD3 exomes
AF:
0.0000686
AC:
14
AN:
204056
Hom.:
0
AF XY:
0.0000725
AC XY:
8
AN XY:
110382
show subpopulations
Gnomad AFR exome
AF:
0.000265
Gnomad AMR exome
AF:
0.000266
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000202
Gnomad OTH exome
AF:
0.000431
GnomAD4 exome
AF:
0.0000257
AC:
36
AN:
1401430
Hom.:
0
Cov.:
29
AF XY:
0.0000260
AC XY:
18
AN XY:
693286
show subpopulations
Gnomad4 AFR exome
AF:
0.000262
Gnomad4 AMR exome
AF:
0.000282
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000920
Gnomad4 OTH exome
AF:
0.000156
GnomAD4 genome
AF:
0.000171
AC:
26
AN:
152194
Hom.:
0
Cov.:
32
AF XY:
0.000121
AC XY:
9
AN XY:
74422
show subpopulations
Gnomad4 AFR
AF:
0.000265
Gnomad4 AMR
AF:
0.000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.000947
Alfa
AF:
0.000285
Hom.:
0
Bravo
AF:
0.000264
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000577
AC:
7

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 10, 2023The c.130C>G (p.P44A) alteration is located in exon 2 (coding exon 2) of the SPTLC3 gene. This alteration results from a C to G substitution at nucleotide position 130, causing the proline (P) at amino acid position 44 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
0.66
DANN
Benign
0.33
DEOGEN2
Benign
0.0041
T;T;T
Eigen
Benign
-2.1
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.11
N
LIST_S2
Benign
0.53
T;T;T
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.023
T;T;T
MetaSVM
Uncertain
-0.14
T
MutationAssessor
Benign
0.82
.;L;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.88
N;N;N
REVEL
Benign
0.27
Sift
Benign
0.46
T;T;T
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0
.;B;.
Vest4
0.11
MVP
0.48
MPC
0.20
ClinPred
0.011
T
GERP RS
-6.6
Varity_R
0.017
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs374808387; hg19: chr20-13029605; API